Skip to content

Study the effect of a oral medicine in autism disorder

Randomized controlled clinical trial to study the effect of herbomineral formulation in autism spectrum disorder - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105469
Enrollment
15
Registered
2026-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F840- Autistic disorder

Interventions

None listed

Sponsors

Bharati Vidyapeeth (Deemed to be University)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a) Children of either gender, aged between 2 - 10 years b) Diagnosed with Autism spectrum disorder(Diagnostic and Statistical Manual of Mental Disorders V criteria) c) Children in the vicinity of the Dhankawadi area. d) Parents who are willing to give consent for the child s participation in the study

Exclusion criteria

Exclusion criteria: a) Children on anti-epileptic medications. b) ASD medications from any other disciplines for more than 1 week. c) Children with co-morbid conditions like cerebral palsy, mental retardation or any other chronic neurological or metabolic disorders. d) Known case of any known syndrome.

Design outcomes

Primary

MeasureTime frame
The primary outcome is to correct the impairment of social interaction and improve communication and imagination in children with ASD, along with the correction of repetitive behaviour, along with achievement of eye contact and being able to respond when called by name. Timepoint: 90 days

Secondary

MeasureTime frame
Secondary outcome is acquisition of speech and languageTimepoint: 90 days

Countries

India

Contacts

Public ContactDr Saniya Pathan

College of Ayurved, Bharati Vidyapeeth (Deemmed to be University)

Meera.panicker@bharatividyapeeth.edu919645238984

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026